Katharine Abbott-Banner

Katharine Abbott-Banner is a prominent inventor based in London, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of respiratory diseases and male infertility. With a total of 2 patents, her work is paving the way for innovative therapeutic solutions.

Latest Patents

Her latest patents focus on a compound designed to treat or prevent various diseases, including cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma, and more. The compound, known as 9,10-dimethoxy-2-(2,4,6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one, modulates CFTR activity to provide therapeutic benefits. Additionally, her inventions include compositions that combine this compound with leukotriene receptor antagonists and CFTR potentiators or correctors, enhancing treatment efficacy.

Career Highlights

Katharine is currently associated with Verona Pharma Plc, where she continues to innovate in the pharmaceutical sector. Her work is characterized by a commitment to addressing complex medical conditions through advanced research and development.

Collaborations

She collaborates with notable colleagues, including John Hanrahan and David Thomas, to further her research and development efforts. Their combined expertise contributes to the advancement of therapeutic solutions in the industry.

Conclusion

Katharine Abbott-Banner's contributions to pharmaceutical innovations are noteworthy, and her ongoing work promises to impact the treatment of various diseases significantly. Her dedication to improving patient outcomes through innovative compounds and compositions is commendable.

Profile summary based on public USPTO records.